CIK 0001787306
- Large accelerated filer
Arcutis Biotherapeutics, Inc.
Sign in to watch- Ticker
- ARQT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812974255
- Phone
- +1 805-418-5006
- Business address
- 3027 TOWNSGATE ROAD, SUITE 300, WESTLAKE VILLAGE, CA, 91361
- Former names
- Arcutis, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,253,826
- in 9 filings, $2.1M under 10b5-1 plans
Net −$3,253,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-13 | Burnett Patrick | Returned to the company · Stock Option (right to buy) | −47,100 | 0 | ||
| 2024-02-13 | Burnett Patrick | Returned to the company · Stock Option (right to buy) | −55,800 | 0 | ||
| 2024-02-13 | Matsuda Masaru | Grant or award | +74,000 | 148,634 | ||
| 2024-02-13 | Matsuda Masaru | Grant or award | +17,650 | 166,284 | ||
| 2024-02-13 | Matsuda Masaru | Grant or award | +27,900 | 194,184 | ||
| 2024-02-13 | Matsuda Masaru | Returned to the company · Stock Option (right to buy) | −185,000 | 0 | ||
| 2024-02-13 | Matsuda Masaru | Returned to the company · Stock Option (right to buy) | −35,300 | 0 | ||
| 2024-02-13 | Matsuda Masaru | Returned to the company · Stock Option (right to buy) | −55,800 | 0 | ||
| 2024-02-13 | Watanabe Todd Franklin | Grant or award | +21,666 | 648,685 | ||
| 2024-02-13 | Watanabe Todd Franklin | Grant or award | +33,066 | 681,751 | ||
| 2024-02-13 | Watanabe Todd Franklin | Grant or award | +94,050 | 775,801 | ||
| 2024-02-13 | Watanabe Todd Franklin | Grant or award | +116,100 | 891,901 | ||
| 2024-02-13 | Watanabe Todd Franklin | Returned to the company · Stock Option (right to buy) | −65,000 | 0 | ||
| 2024-02-13 | Watanabe Todd Franklin | Returned to the company · Stock Option (right to buy) | −99,200 | 0 | ||
| 2024-02-13 | Watanabe Todd Franklin | Returned to the company · Stock Option (right to buy) | −188,100 | 0 | ||
| 2024-02-13 | Watanabe Todd Franklin | Returned to the company · Stock Option (right to buy) | −232,200 | 0 | ||
| 2024-02-13 | Smither John W Chief Financial Officer | Grant or award | +2,793 | 2,793 | ||
| 2024-02-13 | Smither John W Chief Financial Officer | Grant or award | +8,572 | 11,365 | ||
| 2024-02-13 | Smither John W Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −8,379 | 0 | ||
| 2024-02-13 | Smither John W Chief Financial Officer | Returned to the company · Stock Option (right to buy) | −25,718 | 0 |
Page 21 of 35 · 689 trades